| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445389 | European Journal of Cancer | 2013 | 9 Pages |
Abstract
Gefitinib and erlotinib had similar efficacies as salvage therapy for advanced NSCLC in Taiwan.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yu-Yun Shao, Wen-Yi Shau, Zhong-Zhe Lin, Ho-Min Chen, Raymond Kuo, James Chih-Hsin Yang, Mei-Shu Lai,